Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276

le Schmidt, J, Braggio, E, Kortuem, KM, Egan, JB, Zhu, YX, Xin, CS, Tiedemann, RE, Palmer, SE, Garbitt, VM, McCauley, D, Kauffman, M, Shacham, S, Chesi, M, Bergsagel, PL, Stewart, AK
Foilsithe 2013

Genetic aberrations and survival in plasma cell leukemia

le Tiedemann, RE, Gonzalez-Paz, N, Kyle, RA, Santana-Davila, R, Price-Troska, T, Van Wier, SA, Chng, WJ, Ketterling, RP, Gertz, MA, Henderson, K, Greipp, PR, Dispenzieri, A, Lacy, MQ, Rajkumar, SV, Bergsagel, PL, Stewart, AK, Fonseca, R
Foilsithe 2008